Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer

Clinical trial NCT03737994 · TERMINATED

Trial details

NCT number: NCT03737994
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Non-Squamous Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2019-07-25
Primary completion: 2021-07-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.